ChiesiLogo.jpg
Chiesi USA Attains Public Benefit Corporation Status, Pledges to Advance Positive Community Impact
January 11, 2019 08:00 ET | Chiesi USA, Inc.
CARY, N.C., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), a Cary-based specialty pharmaceutical company, recently confirmed its designation as a Delaware Public Benefit...
ChiesiLogo.jpg
Chiesi Salutes Neonatal Intensive Care Unit Staff in Honor of Prematurity Awareness Month®
November 14, 2018 09:00 ET | Chiesi USA, Inc.
In partnership with March of Dimes, video featuring parents of preterm infants and NICU staff raises awareness of prematurity through first-hand accounts from the NICU CARY, N.C., Nov. 14, 2018 ...
ChiesiLogo.jpg
Chiesi Salutes Nurses Surrounding Neonatal Nurses Day 2018
September 18, 2018 08:00 ET | Chiesi USA, Inc.
Neonatal nurses celebrated by hospital colleagues and Chiesi for their commitment to babies CARY, N.C., Sept. 18, 2018 (GLOBE NEWSWIRE) -- For the second consecutive year, Chiesi (key-A-zee), a...
Chiesi in the Community / Durham Bulls
Chiesi Partnership with Durham Bulls Closes Season with $15,000 to Area Nonprofits
September 06, 2018 08:00 ET | Chiesi USA, Inc.
CARY, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Leading into the first pitch at the Durham Bulls August 31 home game against the Norfolk Tides, Chiesi (key-A-zee), a Cary-based specialty...
Members of the Chiesi USA team
Chiesi USA, Inc. Named a Best Place to Work
August 22, 2018 08:00 ET | Chiesi USA, Inc.
CARY, N.C., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), a Cary-based specialty pharmaceutical company, was recently named among Triangle Business Journal’s 2018 Best Places to...
ChiesiLogo.jpg
Chiesi Foundation Onlus Issues 2018 Call for Scientific Research Proposals
August 14, 2018 08:00 ET | Chiesi USA, Inc.
Scientists and researchers are invited to submit proposals for Research in neonatology and pulmonology CARY, N.C., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Chiesi Foundation Onlus (key-A-zee) announced...
ChiesiLogo.jpg
Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)
June 12, 2018 08:00 ET | Chiesi USA, Inc.
CARY, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), a specialty pharmaceutical company based in Cary, N.C., and the Italian biotech Holostem Terapie Avanzate S.r.l., announced that...
ChiesiLogo.jpg
Triangle Business Journal Awards Chiesi USA, Inc. Second Consecutive Corporate Philanthropy Award
May 21, 2018 11:31 ET | Chiesi USA, Inc.
CARY, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, N.C., was awarded the Triangle Business Journal’s Corporate Philanthropy Award...
ChiesiLogo.jpg
Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run
April 27, 2018 09:00 ET | Chiesi USA, Inc.
CARY, N.C., April 27, 2018 (GLOBE NEWSWIRE) -- Chiesi is proud to be named the signature sponsor of the 2018 Triangle March for Babies Walk & 5K Run – the organization’s most recognized event...
ChiesiLogo.jpg
Chiesi and Durham Bulls Partnership is a Home Run for Local Charities
April 05, 2018 09:00 ET | Chiesi USA, Inc.
CARY, N.C., April 05, 2018 (GLOBE NEWSWIRE) -- Officially swinging into baseball season today, Chiesi (key-A-zee), a Cary-based specialty pharmaceutical company, is partnering with the Durham Bulls...